Clinical Trial Update: S0350 Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Peripheral T-Cell Non-Hodgkin's Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the S0350 combination chemotherapy regimen in newly diagnosed stage II-IV peripheral T-cell non-Hodgkin lymphoma has completed enrollme…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral T-cell Non-hodgkin Lymphoma

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2014-08-29